Abstract
Circumscribed choroidal hemangioma (CCH) is rarely associated with choroidal neovascularization (CNV), especially in HIV-infected patients. And the therapy is still controversial. In this study, we discussed the mechanism, clinical feature and treatment of such lesions, based on multi-modality imaging evidences. Photodynamic therapy (PDT) might aggravate CNV as a side effect, and we concluded that intravitreal ranibizumab could be suggested as an effective therapy.
Keywords:
Choroidal neovascularization; Circumscribed choroidal hemangioma; Enhanced depth imaging optical coherence tomography; HIV; Photodynamic therapy.
Copyright © 2014 Elsevier B.V. All rights reserved.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Angiogenesis Inhibitors / administration & dosage
-
Antibodies, Monoclonal, Humanized / administration & dosage*
-
Antineoplastic Agents / administration & dosage
-
Choroid Neoplasms / complications
-
Choroid Neoplasms / drug therapy*
-
Choroid Neoplasms / pathology
-
Choroidal Neovascularization / complications
-
Choroidal Neovascularization / drug therapy*
-
Choroidal Neovascularization / pathology
-
Drug Therapy, Combination / methods
-
Female
-
HIV Infections / complications
-
HIV Infections / drug therapy*
-
HIV Infections / pathology
-
Hemangioma / complications
-
Hemangioma / drug therapy*
-
Hemangioma / pathology
-
Humans
-
Intravitreal Injections
-
Middle Aged
-
Photochemotherapy / methods*
-
Photosensitizing Agents / administration & dosage
-
Ranibizumab
-
Treatment Outcome
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Photosensitizing Agents
-
Ranibizumab